At the news
? NEUTRALIMPACT 4/10 CLUSTER filed Mar 19, 2026 at 16:30 ET
United Therapeutics insiders executed a cluster of derivative exercises and open-market sales over the past week, led by CEO Martine Rothblatt and CFO James Edgemon. The activity includes $5.7 million in exercised derivative value and $467,238 in open-market share sales, representing routine equity management rather than a material shift in sentiment.
- CEO Martine Rothblatt exercised derivatives for 38,000 shares at $146.03 (total value $5.55M) and sold 440 shares for $229,936 in open market.
- CFO James Edgemon exercised derivatives for 20,000 shares at $135.42 (value $2.71M) and sold 200 shares for $103,657.
- Director Tommy Thompson exercised derivatives for 4,000 shares at $101.80 (value $407,200) and sold 275 shares for $147,845.
- Director Judy Olian sold 200 shares for $106,000.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access